Citation Impact

Citing Papers

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
1979
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Heart rate variability: Origins, methods, and interpretive caveats
1997 Standout
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
2000 StandoutNobel
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2008 Standout
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Pulmonary hypertension in sarcoidosis: A review
2010
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Clinical classification of pulmonary hypertension
2004 Standout
Bedside Diagnosis of Systolic Murmurs
1988
Sarcoidosis-Associated Pulmonary Hypertension
2006
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
2005
Sarcoidosis
2013 Standout
Incidence and natural course of trabecular ventricular septal defect: Two-dimensional echocardiography and color Doppler flow imaging study
1992
Prevalence of congenital heart disease
2004 Standout
Demonstration of restrictive ventricular physiology by Doppler echocardiography
1988
Differentiation of cardiac murmurs by dynamic auscultation
1988
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
The incidence of congenital heart disease
2002 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Myocarditis
2000 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Restrictive Cardiomyopathy
1997
Sarcoidosis
2007 Standout
Pulmonary hypertension complicating sarcoidosis
2012
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans
1988
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
Natural History of Congenital Heart Disease
1968
Time Required for Complete Recovery from Chronic Propranolol Therapy
1973
Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease
1979 Standout
Assignment of patients into the classification of cardiomyopathies.
1992
The Effect of Pregnancy on the Murmurs of Mitral and Aortic Regurgitation
1970
Pharmacologic antagonism of beta-adrenergic blockade in dogs
1979
Coronary Artery Syndromes After Sudden Propranolol Withdrawal
1974
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
1999 Standout
Sarcoidosis-Associated Pulmonary Hypertension
2017
Diagnosis of Left-Sided Regurgitant Murmurs by Transient Arterial Occlusion: A New Maneuver Using Blood Pressure Cuffs
1986
Nonoperative Dilatation of Coronary-Artery Stenosis
1979 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Anomalous Origin of the Left Coronary Artery from the Pulmonary Trunk
1968 Standout
Primary pulmonary hypertension
1951
Natural history of ventricular septal defect.
1971
The natural history of ventricular septal defects in infancy
1965
Elevated beta-adrenergic receptor number after chronic propranolol treatment
1977 StandoutNobel
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
DETERIORATION OF GLUCOSE TOLERANCE IN HYPERTENSIVE PATIENTS ON PROLONGED DIURETIC TREATMENT
1976
Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease.
1977
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Role of cardiac biopsy in the diagnosis and management of cardiac disease
1984
The Syndrome of Papillary Muscle Dysfunction
1963
Part 14: Pediatric Advanced Life Support
2010 Standout
Aneurysmal protrusion of the posterior leaflet of the mitral valve
1966
Primary Pulmonary Hypertension
1987 Standout

Works of M Nellen being referenced

Effects of prompt squatting on the systolic murmur in idiopathic hypertrophic obstructive cardiomyopathy.
1967
The atypical systolic murmur of minute ventricular septal defect and its recognition by amyl nitrite and phenylephrine
1961
Ventricular septal defect: the clinical spectrum.
1965
Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
1969
THE USE OF AMYL NITRITE IN THE DIAGNOSIS OF SYSTOLIC MURMURS
1959
The value of squatting in the diagnosis of mild aortic regurgitation
1969
WITHDRAWAL OF PROPRANOLOL AND MYOCARDIAL INFARCTION
1973
Hemodynamic effects of amyl nitrite and phenylephrine on the normal human circulation and their relation to changes in cardiac murmurs
1961
Reversible pulmonary hypertension in sarcoidosis
1982
Idiopathic Pulmonary Hypertension
2010
Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease.
1977
Effect of frusemide on carbohydrate metabolism, blood-pressure, and other modalities. A comparison with chlorothiazide.
1966
Rankless by CCL
2026